Strategy & Innovation
As healthcare costs rise and outcomes remain inconsistent, with rising federal deficits, the question of how to fund the investments in new care models and strategies needed to reform care has become more urgent. Private investors, including venture funds, strategic partners and private equity, are a substantial and growing source of capital and support for reforming healthcare. But what role should these investors play? Which partnerships truly drive progress for patients, providers and communities? And, crucially, how can their impact on health, access and affordability be effectively measured?
In this dynamic session, we invite healthcare executives, funders and innovators to discuss the pros, cons, opportunities and challenges—and importantly, what's next? Presenters will share insights on structuring partnerships that bring lasting value to patients and communities. Join us for a thought-provoking discussion on how to leverage public and private investments to foster meaningful, measurable change in healthcare.
Cheryl Pegus, MD, FACC
Managing Director
Morgan Health Ventures
Mark McClellan, PhD
Director/Robert J. Margolis, MD, Professor of Business, Medicine and Policy
Duke-Margolis Institute for Health Policy at Duke University